RTOG 0117 Plan Scoring
PTV Scoring Dose level 2: 74 Gy |
||
No Variation |
Minor Variation |
Major Variation |
Minimum Dose to PTV is
at, or above 68.8 Gy, and |
95% of PTV1 is at, or above 68.8 Gy and |
Failure to achieve either No Variation or Minor
Variation |
Dose heterogeneity < 10%. (MaxdosePTV/84Gy
<1.10) |
Dose heterogeneity < 10%. (MaxdosePTV/84Gy
<1.10) |
Organs at Risk (OAR)
This protocol has specific dose constraints for critical structures
that must be followed for patients entered on this protocol.
Lung Constraint |
No more than 30%
volume shall receive dose that exceeds 20 Gy |
Esophagus
Constraint |
No more than 30%
volume shall receive dose that exceeds 55 Gy, and the
mean esophageal dose shall be < 34 Gy |
The maximum point dose to
critical normal structures outside the PTV including unspecified tissue should
not exceed the prescription dose. In addition to the dosimetric
normal structure limits noted above, the treating physician must carefully
consider the tolerance dose/volume to each critical normal structure and
unspecified tissue.